CytoDyn Interview to Air on Bloomberg International on the RedChip Money Report

CytoDyn Reports Continued Positive Clinical Data on its Phase 1b/2 mTNBC and Expanded Access Studies for MBC Ahead of Breakthrough Therapy Designation Decision From the FDA

CROI Meeting

Mar 9, 2020 • 2:30 pm EST

Keystone Symposia on HIV Pathogenesis and Cure

Mar 26, 2020 • 2:30 pm MST